What is the NOAEL for 4-Chloro-3,5-dimethylphenol?
4-Chloro-3,5-dimethylphenol has 63 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
Also known as: 4-Chloro-3,5-xylenol, Chloroxylenol, BRN 1862539, Caswell No. 218, 2-Chloro-m-xylenol (+15 more)
CAS 88-04-0
4-Chloro-3,5-dimethylphenol (CAS 88-04-0) is a chemical substance. Key regulatory status: REACH registered, 12 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH.
CAS, identifiers, formula, and alternate names for the matched substance record.
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| active_ingredient; Pesticides | State of California | State of California |
| pharmaceutical | US International Trade Commission | CPCat |
| CEDI | FDA | United States Food and Drug Administration (FDA) |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| active_ingredient; Europe; Pesticides | Commission of the European Communities | CPCat |
| Europe; Personal care | European Commission | CosIng |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| IFRA Transparency | IFRA | IFRA |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 26.5830899111702 | uM | AC50 | - | - | NTP_ICE_endocrine |
| 19.5617571911442 | uM | ACC | - | - | NTP_ICE_endocrine |
| 30 | % | Concentration, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4 | % | Concentration, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 1 | unitless | EPA Classification | Ocular | Rabbit | NTP_ICE_eye_irritation |
| 3 | unitless | EPA classification | Dermal | Rat | NTP_ICE_acute_dermal |
| =3 | Unitless | EPA classification | oral | Rat | NTP_ICE_acute_oral |
| 4 | unitless | EPA classification | Dermal | Rat | NTP_ICE_acute_dermal |
| 4 | unitless | EPA classification | Dermal | Rabbit | NTP_ICE_skin_irritation |
| 4 | unitless | EPA classification | Dermal | Rabbit | NTP_ICE_skin_irritation |
| 0F32U78V2Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0F32U78V2Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0F32U78V2Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0F32U78V2Q | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 4 | unitless | GHS Classification | Inhalation | - | NTP_ICE_acute_inhalation |
| 5 | unitless | GHS Classification | Inhalation | - | NTP_ICE_acute_inhalation |
| 5 | unitless | GHS classification | Dermal | Rat | NTP_ICE_acute_dermal |
| =5 | Unitless | GHS classification | oral | Rat | NTP_ICE_acute_oral |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 3.333 | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 3488 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 6975 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 13950 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 22500 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| 33750 | ug/cm2 | Induction dose per skin area, 5% incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 4500 | ug/cm2 | Induction dose per skin area, one positive response | Dermal | Human | NTP_ICE_skin_sensitization |
| 2.26 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| 6.29 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| >2000 | mg/kg | LD50 | Dermal | Rat | NTP_ICE_acute_dermal |
| =3830 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| >5050 | mg/kg | LD50 | Dermal | Rat | NTP_ICE_acute_dermal |
| =213 | mg/kg bw/day | LEL | dermal | Mouse | ToxValDB_ToxRefDB |
| =213 | mg/kg bw/day | LEL | dermal | mouse (cd1; Crl:CD-1(ICR)BR) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =284 | mg/kg bw/day | LEL | dermal | Mouse | ToxValDB_ToxRefDB |
| =284 | mg/kg bw/day | LEL | dermal | mouse (cd1; Crl:CD-1(ICR)BR) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =300 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =300 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =500 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =500 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | ToxRefDB_ToxRefDB_v3_pod.csv |
| >1000 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =1250 | mg/kg bw/day | LEL | oral | Rat | ToxValDB_ToxRefDB |
| =1250 | mg/kg bw/day | LEL | oral | rat (sprague dawley; Sprague Dawley) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =7900 | mg/m3 | LEL | inhalation | Rat | ToxValDB_ECHA_IUCLID |
| =1000 | mg/kg bw/day | LOAEL | oral | rat (sprague dawley; Sprague Dawley (CD)) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =2500 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ToxRefDB |
| =2500 | mg/kg bw/day | LOAEL | oral | rat (sprague dawley; Sprague Dawley) | ToxRefDB_ToxRefDB_v3_pod.csv |
| =0.5 | mL/kg-day | LOEL | oral | Dog | ToxValDB_ECOTOX |
| =5 | mL/kg-day | LOEL | oral | Dog | ToxValDB_ECOTOX |
| =25 | % | LOEL | dermal | Mouse | ToxValDB_ECOTOX |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
Showing 50 of 63 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 4-chloro-3,5-xylenol | 201-793-8 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
4-Chloro-3,5-dimethylphenol has 63 NOAEL studies in the database. The lowest reported value is 0 % via Dermal in Human. Source: NTP_ICE_skin_sensitization.
4-Chloro-3,5-dimethylphenol appears on 8 regulatory/inventory lists including active_ingredient; Pesticides, pharmaceutical, CEDI, and 5 more. Source: EPA CPDat.
Yes, 4-Chloro-3,5-dimethylphenol is also indexed as a cosmetic ingredient under the name Chloroxylenol (PCMX). View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
4-Chloro-3,5-dimethylphenol also appears in cosmetics, pharmaceutical databases.